Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Am J Transplant. 2016 Mar 17;16(6):1909–1916. doi: 10.1111/ajt.13714

Table 3.

Differences in glucose tolerance profile, LT vs. NHANES controls*

Impaired glucose tolerance Normal glucose tolerance
LT recipients
(n=23)
NHANES controls
(n=15)
p LT recipients
(n=53)
NHANES controls
(n=220)
p
Female 57% 53% 0.85 40% 44% 0.28
Age (years) 16.6 (13.2–20.2) 14.0 (12.0–19.0) 0.20 15.4 (10.6–18.2) 16.0 (13.0–19.0) 0.03
Overweight or obese 26% 60% 0.04 26% 40% 0.05
Fasting glucose (mg/dL) 91 (87–94) 102 (100–108) 0.003 92 (87–98) 93 (88–97) 0.79
2-hour glucose (mg/dL) 156 (147–173) 147 (140–166) 0.09 114 (99–122) 96 (81–109) <0.001
Fasting insulin (mU/mL) 10.60 (7.00–13.60) 21.04 (11.01–29.54) 0.03 10.30 (7.60–15.90) 11.72 (7.63–17.39) 0.74
HOMA-IR 2.25 (1.56–3.59) 5.25 (2.72–8.46) 0.02 2.40 (1.68–3.67) 2.67 (1.71–4.19) 0.77
HOMA-%B 136 (105–253) 201 (115–242) 0.42 131 (105–205) 138 (96–208) 0.89
Hemoglobin A1c 4.9 (4.8–5.2) 5.3 (5.1–5.5) <0.001 4.9 (4.5–5.2) 5.3 (5.1–5.5) <0.001
*

Data represents median (interquartile range) or proportion, with p by Kruskal-Wallis or chi-squared testing, respectively.